Maximum quantity allowed is 999
请选择数量
CAS RN: 34233-69-7 | 产品编码: C3891
Clozapine N-Oxide
×
![]()
×
纯度/分析方法: >95.0%(T)(HPLC)
别名：
- 氯氮平 N-氧化物
- 8-氯-11-(4-甲基-4-氧化-1-哌嗪基)-5H-二苯并[b,e][1,4]二氮杂卓
- 4-(8-氯-5H-二苯并[b,e][1,4]二氮杂卓-11-基)-1-甲基哌嗪1-氧化物
- 8-Chloro-11-(4-methyl-4-oxido-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine
- 4-(8-Chloro-5H-dibenzo[b,e][1,4]diazepin-11-yl)-1-methylpiperazine 1-Oxide
产品文档：
| 产品编码 | C3891 |
| 纯度/分析方法 | >95.0%(T)(HPLC) |
| 分子式/分子量 | C__1__8H__1__9ClN__4O = 342.83 |
| 外观与形状（20°C） | 固体 |
| 储存温度 | 冷冻 (<0°C) |
| 储存在惰性气体下 | 存放于惰性气体之中 |
| 应避免的情况 | 空气,加热 |
| CAS RN | 34233-69-7 |
| Reaxys-RN | 7044724 |
| MDL编号 | MFCD00210190 |
技术规格
| Appearance | White to Yellow powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| Purity(Nonaqueous Titration) | min. 95.0 % |
| NMR | confirm to structure |
物性（参考值）
GHS
| 象形图 |
|
| 信号词 | Danger |
| 危险性说明 | H301 : Toxic if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
| 防范说明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
相关法规
| RTECS# | HP1760000 |
运输信息
| UN编号 | UN2811 |
| 类别 | 6.1 |
| 包装类别 | III |
| HS编码* | 2933.59-000 |
应用
Clozapine N-Oxide: A Selective Activator of a Series of Engineered Muscarinic Acetylcholine Receptors
Clozapine N-oxide is a major and pharmacologically inert metabolite of clozapine [C2547], a dibenzodiazepine "atypical" antipsychotic agent.1,2) Recently, clozapine N-oxide has received attention as a selective activator of designer receptors exclusively activated by designer drugs (DREADDs), a series of engineered muscarinic acetylcholine receptors (mAChRs) that respond exclusively to the synthetic ligand clozapine N-oxide.3-5) (The product is for research purpose only.)
Reference
- 1) Metabolism and bioactivation of clozapine by human liver in vitro
- 2) The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine
- 3) Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand
- 4) Chemogenetics revealed: DREADD occupancy and activation via converted clozapine
- 5) Modulating dopamine signaling and behavior with chemogenetics: concepts, progress, and challenges (a review)
产品文档 (部分产品的分析图谱无法提供，敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助，请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注：该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉，您搜索的分析图谱无法提供。